| Ident. | Authors (with country if any) | Title |
|---|
| 003B17 (2007) |
Gijs A. Versteeg [Pays-Bas] ; Paula S. Van De Nes [Pays-Bas] ; Peter J. Bredenbeek [Pays-Bas] ; Willy J. M. Spaan [Pays-Bas] | The coronavirus spike protein induces endoplasmic reticulum stress and upregulation of intracellular chemokine mRNA concentrations |
| 003B18 (2007) |
Scott R. Schaecher [États-Unis] ; Jason M. Mackenzie [Australie] ; Andrew Pekosz [États-Unis] | The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles |
| 003B19 (2007) |
Monique Oostra [Pays-Bas] ; Cornelis A. M. De Haan [Pays-Bas] ; Peter J. M. Rottier [Pays-Bas] | The 29-Nucleotide Deletion Present in Human but Not in Animal Severe Acute Respiratory Syndrome Coronaviruses Disrupts the Functional Expression of Open Reading Frame 8 |
| 003B28 (2007) |
Sarah A. Kopecky-Bromberg [États-Unis] ; Luis Martinez-Sobrido [États-Unis] ; Matthew Frieman [États-Unis] ; Ralph A. Baric [États-Unis] ; Peter Palese [États-Unis] | Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists⊇ |
| 003B31 (2007) |
Marc G. Wathelet [États-Unis] ; Melissa Orr [États-Unis] ; Matthew B. Frieman [États-Unis] ; Ralph S. Baric [États-Unis] | Severe acute respiratory syndrome coronavirus evades antiviral signaling : Role of nspl and rational design of an attenuated strain |
| 003B45 (2007) |
Els Keyaerts [Belgique] ; Leen Vijgen [Belgique] ; Christophe Pannecouque [Belgique] ; Els Van Damme [Belgique] ; Willy Peumans [Belgique] ; Herman Egberink [Pays-Bas] ; Jan Balzarini [Belgique] ; Marc Van Ranst [Belgique] | Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle |
| 003B53 (2007) |
M. Oostra [Pays-Bas] ; E. G. Te Lintelo [Pays-Bas] ; M. Deijs [Pays-Bas] ; M. H. Verheije [Pays-Bas] ; P. J. M. Rottier [Pays-Bas] ; C. A. M. De Haan [Pays-Bas] | Localization and membrane topology of coronavirus nonstructural protein 4: Involvement of the early secretory pathway in replication |
| 003B61 (2007) |
Ying-Kit Cheung [Hong Kong] ; Samuel Chak-Sum Cheng [Hong Kong] ; Fion Wan-Yee Sin [Hong Kong] ; Kin-Tak Chan [Hong Kong] ; YONG XIE [Hong Kong] | Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope |
| 003B63 (2007) |
Alexander N. Zakhartchouk [Canada] ; Chetna Sharon [Canada] ; Malathy Satkunarajah [Canada] ; Thierry Auperin [Canada] ; Sathiyanarayanan Viswanathan [Canada] ; George Mutwiri [Canada] ; Martin Petric [Canada] ; Raymond H. See [Canada] ; Robert C. Brunham [Canada] ; B. Brett Finlay [Canada] ; Cheryl Cameron [Canada] ; David J. Kelvin [Canada] ; Alan Cochrane [Canada] ; James M. Rini [Canada] ; Lorne A. Babiuk [Canada] | Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice : Implications for a subunit vaccine |
| 003B85 (2007) |
Q.-Y. Yang [République populaire de Chine] ; X.-Y. Tian [République populaire de Chine] ; W.-S. Fang [République populaire de Chine] | Bioactive coumarins from Boenninghausenia sessilicarpa |
| 003B87 (2007) |
F. J. U. M. Van Der Meer [Pays-Bas] ; C. A. M. De Haan [Pays-Bas] ; N. M. P. Schuurman [Pays-Bas] ; B. J. Haijema [Pays-Bas] ; W. J. Peumans [Belgique] ; E. J. M. Van Damme [Belgique] ; P. L. Delputte [Belgique] ; J. Balzarini [Belgique] ; H. F. Egberink [Pays-Bas] | Antiviral activity of carbohydrate-binding agents against Nidovirales in cell culture |
| 003B89 (2007) |
Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Kouji Sakai [Japon] ; Masayuki Saijo [Japon] ; Fumihiro Taguchi [Japon] ; Masaru Yokoyama [Japon] ; Ichiro Kurane [Japon] ; Shigeru Morikawa [Japon] | Amino acid substitutions in the S2 region enhance severe acute respiratory syndrome coronavirus infectivity in rat angiotensin-converting enzyme 2-expressing cells |
| 003B93 (2007) |
Masahiro Ikejiri [Japon] ; Takayuki Ohshima [Japon] ; Keizo Kato [Japon] ; Masaaki Toyama [Japon] ; Takayuki Murata [Japon] ; Kunitada Shimotohno [Japon] ; Tokumi Maruyama [Japon] | 5'-O-Masked 2'-deoxyadenosine analogues as lead compounds for hepatitis C virus (HCV) therapeutic agents |
| 004080 (2006) |
Rakesh Kumar [Canada] ; Wassila Semaine [Canada] ; Monika Johar [Canada] ; D. Lorne J. Tyrrell [Canada] ; Babita Agrawal [Canada] | Effect of Various Pyrimidines Possessing the 1-[(2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl] Moiety, Able To Mimic Natural 2‘-Deoxyribose, on Wild-type and Mutant Hepatitis B Virus Replication |
| 004408 (2006) |
Syaulan Yang [Taïwan] ; Shu-Jen Chen [Taïwan] ; Min-Feng Hsu [Taïwan] ; Jen-Dar Wu [Taïwan] ; Chien-Te K. Tseng [États-Unis] ; Yu-Fan Liu [Taïwan] ; Hua-Chien Chen [Taïwan] ; Chun-Wei Kuo [Taïwan] ; Chi-Shen Wu [Taïwan] ; Li-Wen Chang [Taïwan] ; Wen-Chang Chen [Taïwan] ; Shao-Ying Liao [Taïwan] ; Teng-Yuan Chang [Taïwan] ; Hsin-Hui Hung [Taïwan] ; Hui-Lin Shr [Taïwan] ; Cheng-Yuan Liu [Taïwan] ; Yu-An Huang [Taïwan] ; Ling-Yin Chang [Taïwan] ; Jen-Chi Hsu [Taïwan] ; Clarence J. Peters [États-Unis] ; Andrew H.-J. Wang [Taïwan] ; Ming-Chu Hsu [Taïwan] | Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor |
| 004414 (2006) |
Cheng-Wen Lin [Taïwan] ; Kuan-Hsun Lin [Taïwan] ; Tsung-Han Hsieh [Taïwan] ; Shi-Yi Shiu [Taïwan] ; Jeng-Yi Li [Taïwan] | Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosis |
| 004428 (2006) |
Roberto Di Santo [Italie] ; Roberta Costi [Italie] ; Alessandra Roux [Italie] ; Marino Artico [Italie] ; Antonio Lavecchia [Italie] ; Luciana Marinelli [Italie] ; Ettore Novellino [Italie] ; Lucia Palmisano [Italie] ; Mauro Andreotti [Italie] ; Roberta Amici [Italie] ; Clementina Maria Galluzzo [Italie] ; Lucia Nencioni [Italie] ; Anna Teresa Palamara [Italie] ; Yves Pommier [États-Unis] ; Christophe Marchand [États-Unis] | Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors : Design, synthesis, biological activities, and mechanism of action |
| 004432 (2006) |
Ching-Ping Chan [Hong Kong] ; Kam-Leung Siu [Hong Kong] ; King-Tung Chin [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] ; BOJIAN ZHENG [Hong Kong] ; Dong-Yan Jin [Hong Kong] | Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein |
| 004433 (2006) |
Yu-Ting Yen [Taïwan] ; FANG LIAO [Taïwan] ; Cheng-Hsiang Hsiao [Taïwan] ; Chuan-Liang Kao [Taïwan] ; Yee-Chun Chen [Taïwan] ; Betty A. Wu-Hsieh [Taïwan] | Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro |
| 004437 (2006) |
Jan Balzarini [Belgique] ; Els Keyaerts [Belgique] ; Leen Vijgen [Belgique] ; Herman Egberink [Pays-Bas] ; Erik De Clercq [Belgique] ; Marc Van Ranst [Belgique] ; Svetlana S. Printsevskaya [Russie] ; Eugenia N. Olsufyeva [Russie] ; Svetlana E. Solovieva [Russie] ; Maria N. Preobrazhenskaya [Russie] | Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics |
| 004439 (2006) |
Carla Amici [Italie] ; Antonino Di Caro [Italie] ; Alessandra Ciucci [Italie] ; Lucia Chiappa [Italie] ; Concetta Castilletti [Italie] ; Vito Martella [Italie] ; Nicola Decaro [Italie] ; Canio Buonavoglia [Italie] ; Maria R. Capobianchi [Italie] ; M. Gabriella Santoro [Italie] | Indomethacin has a potent antiviral activity against SARS coronavirus |
